Achaogen, a biopharmaceutical company based in South San Francisco, Calif., filed for Chapter 11 bankruptcy April 15.

Nationwide Children's Hospital in Columbus, Ohio, has quietly become a go-to hub for gene therapy research and production, according to Xconomy National.

As disruptors continue to push into the healthcare arena and pressure builds to cut drug prices, pharmaceutical companies are taking steps to remain competitive and enhance their drug pipelines.

Parents who lost children to the opioid epidemic are pressing Harvard University to strip the Sackler name from one of its museums, according to The Boston Globe.

Duluth, Minn.-based Essentia Health will take over ownership of two pharmacies in Minnesota in June, according to The Brainerd Dispatch.

Contract drug manufacturer Catalent will buy Paragon Bioservices, a privately held company focused on gene therapy production, for $1.2 billion, according to The Wall Street Journal.

A federal judge has declined to dismiss an antitrust suit against "Pharma Bro" Martin Shkreli and Retrophin, the biotech he founded, according to Bloomberg Law.

Becker's Hospital Review has reported the following five drug or biotech company layoffs in the last two weeks. They are listed below, beginning with the most recent.

Despite pushback from several investors, Bristol-Myers Squibb shareholders voted in favor of its $74 billion acquisition of cancer drugmaker Celgene, according to CNBC.

Find out how your retail pharmacy can leverage its supply chain to match your patients' growing expectations.